Innoviva (INVA) Prepaid Assets (2010 - 2026)
Innoviva (INVA) posted Prepaid Assets of $24.8 million for Q1 2026, up 1417.53% on a QoQ basis from $1.6 million in Q4 2025, and up 7836.74% year-over-year from $313000.0 in Q1 2025.
Innoviva (INVA) Prepaid Assets (2010 - 2026) Analysis & Trends
Innoviva's Prepaid Assets history runs 17 years deep, the most recent figure standing at $24.8 million for Q1 2026.
- Quarterly Prepaid Assets rose 7836.74% year-over-year to $24.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $24.8 million (up 7836.74% YoY) and the FY2025 annual result came in at $1.6 million, down 92.23% from the prior year.
- Prepaid Assets was $24.8 million for Q1 2026 at Innoviva, up from $1.6 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $24.8 million in Q1 2026 and bottomed at $181000.0 in Q2 2025.
- A 5-year average of $8.6 million and a median of $2.9 million in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2025 — Prepaid Assets plunged 97.87% — and 2026, when it jumped 7836.74%.
- Innoviva's Prepaid Assets stood at $2.9 million in 2022, then soared by 637.47% to $21.6 million in 2023, then dropped by 2.62% to $21.1 million in 2024, then slumped by 92.23% to $1.6 million in 2025, then surged by 1417.53% to $24.8 million in 2026.
- Business Quant data shows INVA's Prepaid Assets at $24.8 million in Q1 2026, $1.6 million in Q4 2025, and $19.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.84 Mn |
| Dec 31, 2025 | 1.64 Mn |
| Sep 30, 2025 | 19.42 Mn |
| Jun 30, 2025 | 181,000.00 |
| Mar 31, 2025 | 313,000.00 |
| Dec 31, 2024 | 21.06 Mn |
| Sep 30, 2024 | 12.65 Mn |
| Jun 30, 2024 | 8.48 Mn |
| Mar 31, 2024 | 2.99 Mn |
| Dec 31, 2023 | 21.63 Mn |
| Sep 30, 2023 | 1.99 Mn |
| Jun 30, 2023 | 20.54 Mn |
| Mar 31, 2023 | 2.82 Mn |
| Dec 31, 2022 | 2.93 Mn |
| Sep 30, 2022 | 2.43 Mn |
| Jun 30, 2022 | 1.12 Mn |
| Mar 31, 2022 | 1.93 Mn |
| Dec 31, 2021 | 1.37 Mn |
| Sep 30, 2021 | 542,000.00 |
| Jun 30, 2021 | 734,000.00 |